Eli Lilly & Co. (LLY), Incyte (INCY) Announce Baricitinib Phase 3 Met Primary Endpoint in RA
Tweet Send to a Friend
Eli Lilly & Co. (NYSE: LLY)and Incyte Corporation (NASDAQ: INCY) announced positive top-line results of RA-BEGIN, the third Phase 3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
